In addition to posts written by Dana-Farber staff, Insight also occasionally features guest posts from patients, family members and others touched by cancer. If you would like to share your thoughts or experiences with the Insight audience, please let us know. You can email the blog editors at email@example.com.
When you email us, please include your name, best way to contact you and a brief note that tells us what you would like to write about. Blog posts could be on any topic that relates to cancer treatment and research. Guest posts should also follow our general blog comment guidelines.
Communications Department Contributors
Michael Buller is director of Editorial and Creative Services at Dana-Farber, and co-editor of Insight. He leads a team of creative professionals in developing communications and content about cancer research, care, prevention, and survivorship. Michael’s been a writer, editor and content producer for 25 years, a member of the Dana-Farber team for nearly six years, and a Dana-Farber patient for three years.
Christine Cleary is associate director of Editorial and Creative Services at Dana-Farber, co-editor of Insight, and editor of Dana-Farber’s magazine Turning Point, which focuses on women’s cancer. She also oversees patient/family communications, helping to introduce patients to Dana-Farber and ease their experience.
Naomi Funkhouser is the editor of Dana-Farber’s staff publication Inside the Institute. As a member of the Editorial and Creative Services team in the Communications Department, she supports strategic, multi-vehicle communications programs. She earned her bachelor’s degree in magazine journalism from Syracuse University.
Melanie Graham is the Digital Content Producer for Dana-Farber Communications. In her role on the Editorial and Creative Services team, she writes and develops content for Insight and Dana-Farber’s various social media outlets.
MacKenzie Kimball is the intranet web editor for Dana-Farber. In her role on the Interactive Communications team, she manages and develops editorial content for the employee intranet and supports groups throughout the organization in executing their goals for internal messaging.
Robert Levy is a writer and editor at Dana-Farber, covering research advances and topics of interest to staff and the general public.
Richard Saltus is a senior science writer and editor in Dana-Farber Communications. He is a former science and medical writer for the Boston Globe and San Francisco Examiner, and he began his career at the Associated Press.
Eric Schuller is a managing editor at Dana-Farber. He has more than a decade of professional writing and editing experience in a diverse range of corporate and nonprofit industries. At Dana-Farber, he helps create, write, and edit patient-focused materials, with the goal of helping those diagnosed with cancer better navigate their health care landscape.
Shannon Watterson is a communications specialist for Dana-Farber Communications. In her role on the Editorial and Creative Services team, she writes and develops content for patient and family communications, including Insight, to educate and inform patients about the Dana-Farber experience. She is also editor of the Institute’s various e-bulletins for patients and family members.
Saul Wisnia is a senior publications editor at Dana-Farber who contributes to various print and online venues and is an authority on Dana-Farber and Jimmy Fund history. He is the author of numerous books, including The Jimmy Fund of Dana-Farber Cancer Institute, which chronicles the unique relationship between the Boston Red Sox and the Jimmy Fund.
Other Dana-Farber Contributors
Clair J. Beard, MD, is an associate professor of radiation oncology at Harvard Medical School, vice-chair of Genitourinary Radiation Oncology and director of the Testicular Cancer Center at Dana-Farber/Brigham and Women’s Cancer Center.
Rameen Beroukhim, MD, PhD, is a neuro-oncologist whose clinical interests are in somatic genetics of cancer, glioma and meningioma. His research focuses on understanding the heterogeneity observed across cancers through differences in their genomic profiles with a particular interest in the use of high-throughput sequencing technologies to profile large numbers of cancers.
Nancy Borstelmann, LICSW, MPH, serves as Dana-Farber’s director of social work.
Richard Boyajian, RN, MS, ANP, is an oncology nurse practitioner in Dana-Farber’s Adult Survivorship Program, a member of the LIVESTRONG Survivorship Center of Excellence Network.
Harold J. Burstein, MD, PhD, is a medical oncologist in the Breast Cancer Treatment Center at Dana-Farber Cancer Institute.
Nancy Campbell, MS, is an exercise physiologist who offers fitness consults and classes to cancer patients and survivors through Dana-Farber’s Adult Survivorship Program.
Bethany-Rose Daubman, MD, is a fellow in the Harvard Palliative Medicine Fellowship, working at Dana-Farber Cancer Institute, Massachusetts General Hospital, and Brigham and Women’s Hospital. She is interested in helping families making difficult health-care decisions, as well as international palliative care.
Laura Dominici, MD, is a surgical oncologist in the Breast Oncology Center at Dana-Farber/Brigham and Women’s Cancer Center, and an instructor in surgery at Harvard Medical School.
Sarah Feldman, MD, MPH, is the director of Ambulatory Gynecologic Oncology and the Center for Preinvasive Disease of the Lower Genital Tract. She is also an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School.
Robert Haddad, MD, is the disease center leader of the Head and Neck Oncology Program at Dana-Farber and an associate professor of medicine at Harvard Medical School.
Stacy Kennedy, MPH, RD, CSO, LDN, is a senior clinical nutritionist for Dana-Farber and a Board Certified Specialist in Oncology Nutrition.
Ian E. Krop, MD, PhD, is a medical oncologist with the Susan F. Smith Center for Women’s Cancers Breast Oncology Program and an assistant professor of medicine at Harvard Medical School.
Leslie E. Lehmann, MD, is the clinical director of the Pediatric Stem Cell Transplant Program at Dana-Farber/Children’s Hospital Cancer Center.
Erica Mayer, MD, MPH is a medical oncologist and clinical investigator in the Breast Oncology Center at Dana-Farber. Her research focuses on novel therapies in the treatment of breast cancer.
Mark Pomerantz, MD, is a medical oncologist at the Dana-Farber Cancer Institute. He is on faculty in the Lank Center for Genitourinary Oncology.
David Reardon, MD, is the clinical director of the Center for Neuro-Oncology at Dana-Farber. His research interests include brain and spinal tumors, clinical trials in neuro-oncology, targeted therapies, anti-angiogenic treatments, immunotherapy and convection-enhanced delivery.
Julie Salinger, LICSW, is a social worker in the Susan F. Smith Center for Women’s Cancers Breast Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center, where she assists patients and their families with finding supportive resources and dealing with the emotional side of cancer. She also leads Facing Forward support seminars for breast cancer survivors.
Stephen Sallan, MD, is a senior pediatric oncologist at Dana-Farber/Chilrden’s Hospital Cancer Center and chief of staff emeritus at Dana-Farber Cancer Institute.
Lawrence Shulman, MD, is Dana-Farber’s chief of staff and senior vice president for medical affairs. He is also director of regional strategy development and director of the Center for Global Medicine, senior oncology advisor to Partners in Health and associate professor of medicine at Harvard Medical School.
David P. Steensma, MD, FACP, is a medical oncologist in Dana-Farber’s Hematologic Oncology Treatment Center.
Vish Viswanath, PhD, is a professor of health communication in the Department of Social and Behavioral Sciences at Harvard School of Public Health and McGraw-Patterson Center for Population Sciences.
Patrick Wen, MD, is a specialist in cancer of the brain and spinal cord and the director of the Center for Neuro-Oncology at Dana-Farber. His research is focused on novel treatments of brain tumors, especially targeted molecular agents. His other clinical interests include neurologic complications of cancer.
Leonard Ansin is a software developer and prostate cancer survivor. He lives with his wife Jane in the Boston area.
Amy Atwood is a writer, mom, daughter, sister, friend. Lover of travel, books, movies, music, water, photography, history and Boston sports. And now breast cancer survivor. She is also the Communications Manager for Genzyme’s Allston Landing Facility, and blogs about her cancer journey at www.amysamerica.com.
Lisa Belanger was diagnosed with ovarian cancer at the age of 29, while completing her MBA at Boston University. She graduated from BU just four months after her diagnosis and currently works as a financial analyst. Outside of treatment, she enjoys exploring Boston and trying new restaurants. Lisa lives in Weymouth, Mass. with her boyfriend, Patrick.
James (Jim) Bond has been living with multiple myeloma for more than 20 years. He and his wife Kathleen live in Shaker Heights, Ohio.
Kat Caverly is a multi-media artist and bon vivant. She is a greeting card designer, photographer, animator, writer, and comic performer. You can see her in all of her glory on her blog (effectsontheside.com) and on H.UMORO.US (h.umoro.us).
Timothy J. Crowley was born and raised in Holyoke, MA. He served as a Major in the USMC, is a former Secret Service Agent and presently works as a MA State Trooper. He is a husband to breast cancer survivor, Julie, and father to Jack and Kate. Diagnosed with Acute Myeloid Leukemia in June 2010, Tim underwent treatment at Dana Farber including an allogenic stem cell transplant from an unrelated donor.
Catherine Goff is a Hodgkin lymphoma and breast cancer survivor, who was first diagnosed at the age of 21. She is dedicated to advocating for proper screening and education for other survivors to prevent or catch possible recurrences. Catherine lives in Dover, Mass., and enjoys spending time with her five children and raising money for cancer research and patient care.
Rosemary Fischer is a former employee and current patient at Dana-Farber.
Catherine MacLean is a 13-year survivor of a bone marrow transplant for aplastic anemia. She currently works in health policy and delivery research, and in her spare time writes and advocates to bring a voice to the patient experience of serious illness and its aftermath. She also enjoys volunteering as a camp counselor, reading anything she can get her hands on, watching Parks and Recreation, and mini golfing with friends, among other adventures.
Gerardo J. Martinez is principal of the Schofield Elementary School in Wellesley, Mass., and a cancer survivor. He is a loving and playful father of a 4-year-old boy and 8-year-old girl. He is passionate about poetry and boxing.
Lyndsay McCaffery is a stay-at-home mom who lives in Billerica, Mass. She is a trained singer and actor with degrees in both Musical Theatre and Theatre Education.
Abby Morgan is an elementary school art teacher who was diagnosed with metastatic synovial sarcoma in 2013 at the age of 28. Between treatments, she loves to travel, hike, read, cook, garden, and practice her own art. A native Vermonter, she now lives in Stow, Mass., with her husband, dog, and two cats.
Patrick Palmer is currently on leave from his role as President and CEO of the West Suburban YMCA in Newton, Mass. As a former airline pilot, he enjoys golf, fishing, the North End and a good read. He is currently overseeing the fundraising efforts for the Angela & Patrick Palmer Research Fund for Brain Cancer.
Carolyn Ridge was diagnosed with ovarian cancer at the age of 30. While her diagnosis initially interrupted her studies to become a nurse, she is reenrolling in nursing school at Simmons College in fall 2014. Carolyn lives in Natick, Mass., and is dedicated to advocating for other young adult patients at Dana-Farber and beyond.
Buck Rogers was born in Pittsburgh in 1954 and is a piano rebuilder and musician by trade. In remission from CLL for five years, he is now ready for the next battle. Buck lives in Medway, Mass.
Jane Roper is the author of a memoir, Double Time: How I Survived–and Mostly Thrived–Through the First Three Years of Mothering Twins (St. Martin’s Press, 2012), and a novel, Eden Lake (Last Light Studio, 2011). She received her MFA in fiction from the Iowa Writers’ Workshop, and her writing has appeared on Salon, Babble, Poets & Writers, The Rumpus and elsewhere. Jane lives in the Boston area with her husband and twin daughters. (Photo: Sharona Jacobs)
Timothy Rourke is the father of a young cancer survivor, former co-chair of Dana-Farber’s Pediatric Patient and Family Advisory Council, and works for the New Hampshire Charitable Foundation.
Tara Shuman is a 32-year-old lawyer, wife, mother of two, and a breast cancer patient. She blogs about her experience at www.tarabeatscancer.com.
Sheldon Simon is co-chair of the Men’s Collaborative to Cure Women’s Cancers. The group is currently planning its next fundraiser, The 2nd Annual Women’s Cancers Classic.
Sara Dickison Taylor is a co-chair of the Pediatric Patient and Family Advisory Council at Dana-Farber/Children’s Hospital Cancer Center.
Anne Tonachel is a retired preschool teacher and longtime Dana-Farber volunteer. With her husband, Dick, she is also a host with Hospitality Homes, which provides free lodging to families traveling to the Boston area for treatment at 29 local hospitals and medical centers including Dana-Farber.
Kelley Tuthill is a reporter at WCVB TV Channel 5 in Boston and a breast cancer survivor who was treated at Dana-Farber. Tuthill poignantly shared her cancer journey with Channel 5 viewers and on-line users. The cameras followed her from diagnosis, surgery, chemotherapy and radiation to life after cancer. She is also co-author of You Can Do This! Surviving Breast Cancer Without Losing Your Sanity or Your Style.
Tom Ulrich is a senior science writer in Boston Children’s Hospital’s Marketing and Communications Department, covering laboratory and clinical research innovations across the hospital.
Pam Zwemer chairs the math department at the Oscar Smith High School in Chesapeake, Va., and is a Dana-Farber patient.